A-Share Listed Medical Services Companies - Profiles and Financial Data
In China, medical services refer to services provided by medical institutions for patients, including health examination, diagnosis, treatment, recovery, disease prevention and healthcare, delivery, birth planning and other services. Chinese medical institutions include hospitals, township hospitals, community health centers (stations), clinics (health clinic and infirmary), village clinics, disease prevention and control centers and health inspection authorities.
By the end of 2015, there had been 990,248 health and medical institutions, including 27,215 hospitals. Total medical service expenses increased from CNY 1,647.2 billion to CNY 3,250.3 billion at CAGR of 18.5% from 2011 to 2015.
According to CRI analysis, the Chinese society is aging and the medical industry is supported by the government. With the loosening of the family planning policy, it is expected that the population growth will accelerate in the coming years. In addition, worsened aging problem and residents' increasing income have fueled Chinese people's demand for medical services. China's medical industry has a bright future.
In this report, CRI analyzes 11 medical service enterprises listed in A-share market in China.
The report is composed of two parts: the first part is enterprise profiles and the second part is the operation status of these enterprises in the recent decade (presently 2006 to 2016, we will update it to the latest as time goes by).
The operation status is demonstrated from the following perspectives: (1) financial indexes, such as earnings per share, book value per share (BPS), sales per share, net cash flow per share, return on net worth and debt to asset ratio; (2) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (3) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (4) indexes on the balance sheet, such as liquid asset, fixed asset, current liability, non-current liability, capital reserve and shareholders' equity.
(1) Financial Indexes
By the end of 2015, there had been 990,248 health and medical institutions, including 27,215 hospitals. Total medical service expenses increased from CNY 1,647.2 billion to CNY 3,250.3 billion at CAGR of 18.5% from 2011 to 2015.
According to CRI analysis, the Chinese society is aging and the medical industry is supported by the government. With the loosening of the family planning policy, it is expected that the population growth will accelerate in the coming years. In addition, worsened aging problem and residents' increasing income have fueled Chinese people's demand for medical services. China's medical industry has a bright future.
In this report, CRI analyzes 11 medical service enterprises listed in A-share market in China.
The report is composed of two parts: the first part is enterprise profiles and the second part is the operation status of these enterprises in the recent decade (presently 2006 to 2016, we will update it to the latest as time goes by).
The operation status is demonstrated from the following perspectives: (1) financial indexes, such as earnings per share, book value per share (BPS), sales per share, net cash flow per share, return on net worth and debt to asset ratio; (2) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (3) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (4) indexes on the balance sheet, such as liquid asset, fixed asset, current liability, non-current liability, capital reserve and shareholders' equity.
(1) Financial Indexes
- Earnings per Share
- Book Value per Share (BPS)
- Sales per Share (SPS)
- Net Cash Flow per Share from Operations
- Net Cash Flow per Share (CNY)
- Return on Net Worth
- Net Profit Margin on Total Assets
- Return on Invested Capital (ROIC) (%)
- Gross Profit Margin on Sales (%)
- Net Profit Margin on Sales (%)
- EBIT Margin (%)
- EBITDA Margin (%)
- Debt to Asset Ratio (%)
- Total Asset Turnover (times)
- Cash/Operating Income Received from Sales of Goods or Services
- YOY Growth Rate of Operating Revenue (%)
- YOY Growth Rate of Operating Profit (%)
- YOY Growth Rate of Net Profit Attributable to Shareholders of Parent Company (%)
- Gross Revenue (CNY, million)
- Total Operating Costs (CNY, million)
- Revenue (CNY, million)
- Operating Profit (CNY, million)
- Total Profit (CNY, million)
- Net Profit (CNY, million)
- Net Profit Attributable to Shareholders of Parent Company (CNY, million)
- Non-recurring Items (CNY, million)
- Net Profit Deducting Non-recurring Items (CNY, million)
- R&D Costs (CNY, million)
- Earnings Before Interest and Tax (EBIT) (CNY, million)
- Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) (CNY, million)
- Liquid Asset (CNY, million)
- Fixed Asset (CNY, million)
- Long-term Equity Investment
- Total Assets (CNY, million)
- Liquid Liability (CNY, million)
- Non-current Liability (CNY, million)
- Total Liability (CNY, million)
- Capital Reserve (CNY, million)
- Surplus Reserve (CNY, million)
- Undistributed Profit (CNY, million)
- Shareholders' Equity (CNY, million)
- Equity Attributable to Shareholders of Parent Company (CNY, million)
- Cash Received from Sales of Goods and Services (CNY, million)
- Cash Flow from Operations (CNY, million)
- Cash Paid to Purchase Fixed Assets, Intangible Assets and Other Long-term Assets (CNY, million)
- Cash Paid for Investments (CNY, million)
- Cash Flow from Investments (CNY, million)
- Cash Received from Investors (CNY, million)
- Cash Received from Borrowings (CNY, million)
- Cash Flow from Financing (CNY, million)
- Net Increase of Cash and Cash Equivalents (CNY, million)
- Cash and Cash Equivalents, End of Period (CNY, million)
- Depreciation and Amortization (CNY, million)
COMPANIES IN THE REPORT:
1 Top choice Medical Investment Co., Inc. (600763.SH)
2 Shanghai Runda Medical Technology Co., Ltd. (603108.SH)
3 Yihua Healthcare Co., Ltd. (000150.SZ)
4 Jinling Pharmaceutical Company Limited (000919.SZ)
5 Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
6 Hengkang Medical Group Co., Ltd. (002219.SZ)
7 Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
8 Aier Eye Hospital Group Co., Ltd. (300015.SZ)
9 Zhejiang Dian Diagnostics Co., Ltd. (300244.SZ)
10 Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)
11 Guangzhou Boji Medical & Biotechnological Co., Ltd. (300404.SZ)
1 Top choice Medical Investment Co., Inc. (600763.SH)
2 Shanghai Runda Medical Technology Co., Ltd. (603108.SH)
3 Yihua Healthcare Co., Ltd. (000150.SZ)
4 Jinling Pharmaceutical Company Limited (000919.SZ)
5 Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
6 Hengkang Medical Group Co., Ltd. (002219.SZ)
7 Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
8 Aier Eye Hospital Group Co., Ltd. (300015.SZ)
9 Zhejiang Dian Diagnostics Co., Ltd. (300244.SZ)
10 Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ)
11 Guangzhou Boji Medical & Biotechnological Co., Ltd. (300404.SZ)
